Evidence mapPaperPMID 42523700Full record

ArticleFrontiers in cell and developmental biology2026

Toward a cell-type-specific lung HOX code.

Bettina Budeus, Diana Klein

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bettina BudeusMedical Faculty, Institute for Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.
Diana Klein *Medical Faculty, Institute for Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: HOX genes encode transcription factors that are central regulators of cell fate during embryogenesis and of maintaining respective positional cell identity throughout life. Moreover, HOX factors shape the specification of regional properties of the respective tissues, but detailed information regarding the role of HOX genes in the adult human respiratory system is still lacking. Methods: We examined the HOX expression pattern in human lungs using global gene expression analyses of normal lung tissue specimens, followed by quantitative real-time reverse-transcriptase polymerase chain reaction (qRT-PCR). Cell-type specificity was investigated using published single-cell RNA sequencing (scRNAseq) datasets and by immunohistochemistry and immunofluorescence analyses. Results: The expressed HOX candidates HOXA3-HOXA7, HOXB5, HOXB7, and HOXB8, HOXC6-HOXC9, and HOXD1-D8 were localized in healthy lung specimens. Early and central HOXA and HOXB genes were found to be more highly expressed in adult lung tissue, predominantly localizing in stromal cells. While HOXA3 and HOXA5 were primarily localized in sub-bronchial and vascular smooth muscle cells (SMCs), HOXA4, HOXB5, and HOXB7 were predominantly found in vascular mural cells, whereas expression in sub-bronchial regions was more associated with connective tissue cells. HOXA6 was exclusively detected in sub-bronchial and adventitial connective tissue; a similar pattern was observed for HOXA7. HOXA7, HOXB5, and HOXB7, along with HOXD1, were found in the endothelial cells of predominantly larger vessels. Bronchial epithelial cells showed immunoreactivity for almost all the HOX proteins examined, although in some cases, this was limited to single cells. In the alveolar compartment, only HOXA6 (presumably in connective tissue cells), as well as HOXB6, HOXC6, and HOXC8, could be localized. A temporal analysis of the HOX expression development during lung organoid differentiation from induced pluripotent stem cells confirmed respective findings. Conclusion: Since the deregulation of HOX genes is increasingly observed in numerous (malignant) lung diseases, it is a necessary prerequisite to specify individual HOX factors and their cellular origin. This could not only provide better insights into the function of HOX genes in lung diseases but also offer the possibility of improving the regenerative potential through targeted modulation of (cell-type-specific) HOX genes.

Indexed as

alveolarbronchiolarepithelia cellsfibroblastsHOX codelungorganoids

Identifiers

PMID42523700
PMCPMC13407532

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.